Do you want to read an article? Please log in or register.
Terbutaline and aminophylline as second-line therapies for status asthmaticus in the pediatric intensive care unit
Asthma
RECOMMENDED
Related content
RECOMMENDED
COPD
Physical Therapy and Rehabilitation in Chronic Obstructive Pulmonary Disease Patients Admitted to the Intensive Care Unit
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Semin Respir Crit Care Med.
Martí JD, McWilliams D, Gimeno-Santos E
doi: 10.1055/s-0040-1709139.
RECOMMENDED
Pulmonary Hypertension
Mortality from Pulmonary Hypertension in the Pediatric Cardiac Intensive Care Unit
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med
Morell E, Gaies M, Fineman JR, Charpie J, Rao R, Sasaki J, Zhang W, Reichle G, Banerjee M, Tabbutt S
doi: 10.1164/rccm.202011-4183OC
RECOMMENDED
Pneumonia
Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Crit Care
García-Salido A, de Carlos Vicente JC, Belda Hofheinz S, Balcells Ramírez J, Slöcker Barrio M, Leóz Gordillo I, Hernández Yuste A, Guitart Pardellans C, Cuervas-Mons Tejedor M, Huidobro Labarga B, Vázquez Martínez JL, Gutiérrez Jimeno M, Oulego-Erróz I, Trastoy Quintela J, Medina Monzón C, Medina Ramos L, Holanda Peña MS, Gil-Antón J, Sorribes Ortí C, Flores González JC, Hernández Palomo RM, Sánchez Ganfornina I, Fernández Romero E, García-Besteiro M, López-Herce Cid J, González Cortés R, Spanish Pediatric Intensive Care Society working group on SARS-CoV-2 infection.
doi: 10.1186/s13054-020-03332-4
RECOMMENDED
COPD
Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: Antibiotic Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Semin Respir Crit Care Med.
Gupta N, Haley R, Gupta A, Sethi S
doi: 10.1055/s-0040-1708837.
RECOMMENDED
Further Publications
Assessing the need for transfer to the intensive care unit for Coronavirus-19 disease: Epidemiology and risk factors
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Hashmi MD, Alnababteh M, Vedantam K, Alunikummannil J, Oweis ES, Shorr AF
doi: 10.1016/j.rmed.2020.106203
RECOMMENDED
Pneumonia
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post_treatment hospitalisation status
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Pharmacol Res.
Antinori S, Cossu MV, Ridolfo AL, Rech R, Bonazzetti C, Pagani G, Gubertini G, Coen M, Magni C, Castelli A, Borghi B, Colombo R, Giorgi R, Angeli E, Mileto D, Milazzo L, Vimercati S, Pellicciotta M, Corbellino M, Torre A, Rusconi S, Oreni L, Gismondo MR, Giacomelli A, Meroni L, Rizzardini G, Galli M
doi: 10.1016/j.phrs.2020.104899.
RECOMMENDED
Further Publications
Antibiotic Stewardship in the Intensive Care Unit. An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Ann Am Thorac Soc.
Wunderink RG, Srinivasan A, Barie PS, Chastre J, Dela Cruz CS, Douglas IS, Ecklund M, Evans SE, Evans SR, Gerlach AT, Hicks LA, Howell M, Hutchinson ML, Hyzy RC, Kane-Gill SL, Lease ED, Metersky ML, Munro N, Niederman MS, Restrepo MI, Sessler CN, Simpson SQ, Swoboda SM, Guillamet CV, Waterer GW, Weiss CH
doi: 10.1513/AnnalsATS.202003-188ST.
RECOMMENDED
Pneumonia
The Burden of Community-Acquired Pneumonia Requiring Admission to an Intensive Care Unit in the United States
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
doi: 10.1016/j.chest.2020.03.051.
RECOMMENDED
ARDS
Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS: A Randomized Clinical Trial
JAMA.
Writing Group for the PReVENT Investigators, Simonis FD, Serpa Neto A, Binnekade JM, Braber A, Bruin KCM, Determann RM, Goekoop GJ, Heidt J, Horn J, Innemee G, de Jonge E, Juffermans NP, Spronk PE, Steuten LM, Tuinman PR, de Wilde RBP, Vriends M, Gama de Abreu M, Pelosi P, Schultz MJ
doi: 10.1001/jama.2018.14280.